Showing results (151-160 of 171) with videos related to
Sort By:
Pageof 18
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|January 17, 2012
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-)Tony Antoniou, Graham Smith, Desheng Su, et al.AIDS Care|March 15, 2016
Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individualsPaul A Shuper, Narges Joharchi, Hyacinth Irving, et al.AIDS Patient Care and Stds|February 8, 2017
Trends and Correlates of Cigarette Smoking and Its Impacts on Health-Related Quality of Life Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study, 2008-2014Tsegaye Bekele, Sergio Rueda, Sandra Gardner, et al.Plos One|December 14, 2020
Separating the effects of climate, bycatch, predation and harvesting on tītī (Ardenna grisea) population dynamics in New Zealand: A model-based assessmentSam McKechnie, David Fletcher, Jamie Newman, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 2019
Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the AirwaysJessica Jarvela, Michelle Moyer, Patrick Leahy, et al.International Journal of STD & AIDS|April 23, 2021
Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate- to tenofovir alafenamide-containing ART among individuals with HIV in Canada: A retrospective studyMostafa Shokoohi, Meenakshi Gupta, Fred Crouzat, et al.Journal of the International AIDS Society|November 15, 2014
Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profilesFrederic Crouzat, Anita Benoit, Colin Kovacs, et al.Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 22, 2006
Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirinMorris Sherman, Lawrence Cohen, Mary Anne Cooper, et al.AIDS Research and Human Retroviruses|October 6, 2020
Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral RegimensBrenda Varriano, Frederic Crouzat, Ina Sandler, et al.International Journal of STD & AIDS|May 2, 2019
Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimenBrenda Varriano, Ina Sandler, Mona Loutfy, et al.Pageof 18